Healthy AgingNCT06964399
The Effect of Reminiscence Therapy in Older Adults
A study testing Reminiscence therapy in people with Healthy Aging and Aging, run by Muş Alparslan University at 1 site in Turkey (Türkiye).
Trial summary
This randomized controlled study examined the effects of reminiscence therapy on psychological well-being and mindfulness among community-dwelling older adults. A total of 90 participants were randomly assigned to an experimental group or a control group. Read more about this study
- Who is it for?
- Ages 65 to 100 yearsHealthy volunteers can take part
- Conditions the study is for
- Healthy Aging, Aging
- What is being tested?
- Reminiscence therapy
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 90 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Apr 2025to 16 Jun 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 to 100 years
- All sexes
- Healthy volunteers accepted
- Older adult
Who may be able to join
- Being 65 years of age or older,
- Voluntarily agreeing to participate in the study and providing written consent,
- Suitable for the assessment of psychological well-being and mindfulness levels (e.g., not having disorientation and being able to communicate)
Who cannot join
- Having severe dementia, Alzheimer's, or other neurological diseases,
- Being unable to actively participate in the therapy process due to a severe hearing, vision, or speech impairment,
- Having a diagnosis of psychiatric illness (schizophrenia, bipolar disorder, etc.),
- Having experienced a major traumatic life event in the last six months (death, disaster, serious illness, etc.),
- Having undergone a similar therapeutic intervention or psychotherapy process before,
- Individuals who declared that they could not participate regularly during the study period.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Psychological Well-Being and Mindfulness in Older Adults: The Effect of Reminiscence Therapy
This randomized controlled study examined the effects of reminiscence therapy on psychological well-being and mindfulness among community-dwelling older adults. A total of 90 participants were randomly assigned to an experimental group or a control group. The experimental group received a structured reminiscence therapy program, while the control group received no study intervention. Participants completed baseline assessments before the intervention and post-test assessments immediately after completion of the intervention. The study included 45 participants in the experimental group and 45 participants in the control group.
Read the detailed description
This randomized controlled study examined the effects of reminiscence therapy on psychological well-being and mindfulness among community-dwelling older adults. A total of 90 participants were randomly assigned to an experimental group (n=45) or a control group (n=45).
Participants in the experimental group received a structured reminiscence therapy program delivered in five small therapy groups, with nine participants in each group. The intervention consisted of two 90-minute sessions per week for five weeks, for a total of 10 sessions. The sessions addressed age-appropriate reminiscence themes, including getting to know each other, childhood memories, places lived, holidays and festivals, food and cooking, memorable historical periods, favorite music, movies associated with participants' life periods, family life and personal values, life achievements, evaluation, and closure. Photographs, household objects, music, and other reminiscence materials were used to facilitate discussion and recall.
Participants in the control group received no reminiscence therapy or other study intervention during the study period. Psychological well-being and mindfulness were assessed at baseline and immediately after completion of the intervention using the Psychological Well-Being Scale and the Mindful Attention Awareness Scale, respectively.
- Conditions
- Healthy Aging, Aging
- Being tested
- Reminiscence therapy
- Keywords
- Reminiscence Therapy, Older Adults, Psychological Well-Being, Mindfulness
- Medical subject headings
- Psychological Well-Being
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Reminiscence therapyOther
In our study, reminiscence therapy was administered for five weeks, with one session per day, twice a week. Each session lasted an average of 1.5 hours, depending on the responses from the elderly participants. The elderly individuals in the experimental group were divided into five groups. Each group consisted of 9 individuals.
| Study group | Role | What they receive |
|---|---|---|
| Experimental Group | Experimental | Participants assigned to the experimental group (n=45) received a structured reminiscence therapy program over five weeks. The intervention was delivered in five small therapy groups, with nine participants in each group. Two 90-minute sessions were conducted per week, for a total of 10 sessions. The sessions addressed age-appropriate reminiscence themes, including getting to know each other, childhood memories, places lived, holidays and festivals, food and cooking, memorable historical periods, favorite music, movies associated with participants' life periods, family life and personal values, life achievements, evaluation, and closure. Photographs, household objects, music, and other reminiscence materials were used to facilitate discussion and recall. Receives: Other: Reminiscence therapy |
| Control Group | No intervention | Participants assigned to the control group (n=45) received no reminiscence therapy or other study intervention during the study period. They completed the baseline and post-test assessments according to the study schedule. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Psychological well-being Scale
scale score average, It is a single-factor scale consisting of 8 items on a 7-point Likert type. Scores range from 8 to 56. A high score obtained from the scale indicates that the person has many psychological resources and strengths.
Measured: Baseline and immediately after completion of the 5-week intervention
Secondary outcomes (1)
Mindful Attention Awareness Scale
scale score average, It is a single-factor scale consisting of 15 items. Scores range from 15 to 90. It has a single-factor structure that yields a total score, with higher scores reflecting greater levels of mindfulness.
Measured: Baseline and immediately after completion of the 5-week intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 May 2025
- Study start1 Apr 2025
- Primary completion12 May 2025
- Study completion16 Jun 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Healthy AgingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 90 participants (actual)
Sponsor and investigators
- Lead sponsor
- Muş Alparslan University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Güzel Nur YILDIZ, Dr, Principal investigator, Muş Alparslan University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06964399
- Sponsor's protocol ID
- Reminiscence Therapy
- Status last verified
- Sep 2026
- First submitted
- 24 Apr 2025
- Last updated
- 18 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 18 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Psychological Well-Being and Mindfulness in Older Adults: The Effect of Reminiscence Therapy
- ClinicalTrials.gov ID
- NCT06964399
- Acronym / sponsor ID
- Reminiscence Therapy
- Conditions
- Healthy Aging, Aging
- Keywords
- Reminiscence Therapy, Older Adults, Psychological Well-Being, Mindfulness
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 90 participants (actual)
- Lead sponsor
- Muş Alparslan UniversityUniversity, hospital or other
- Study start
- 1 Apr 2025 (actual)
- Primary completion
- 12 May 2025 (actual)
- Study completion
- 16 Jun 2025 (actual)
- First posted
- 9 May 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This randomized controlled study examined the effects of reminiscence therapy on psychological well-being and mindfulness among community-dwelling older adults. A total of 90 participants were randomly assigned to an experimental group or a control group. The experimental group received a structured reminiscence therapy program, while the control group received no study intervention. Participants completed baseline assessments before the intervention and post-test assessments immediately after completion of the intervention. The study included 45 participants in the experimental group and 45 participants in the control group.
Detailed description
This randomized controlled study examined the effects of reminiscence therapy on psychological well-being and mindfulness among community-dwelling older adults. A total of 90 participants were randomly assigned to an experimental group (n=45) or a control group (n=45).
Participants in the experimental group received a structured reminiscence therapy program delivered in five small therapy groups, with nine participants in each group. The intervention consisted of two 90-minute sessions per week for five weeks, for a total of 10 sessions. The sessions addressed age-appropriate reminiscence themes, including getting to know each other, childhood memories, places lived, holidays and festivals, food and cooking, memorable historical periods, favorite music, movies associated with participants' life periods, family life and personal values, life achievements, evaluation, and closure. Photographs, household objects, music, and other reminiscence materials were used to facilitate discussion and recall.
Participants in the control group received no reminiscence therapy or other study intervention during the study period. Psychological well-being and mindfulness were assessed at baseline and immediately after completion of the intervention using the Psychological Well-Being Scale and the Mindful Attention Awareness Scale, respectively.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Experimental Group | Experimental | Other: Reminiscence therapyParticipants assigned to the experimental group (n=45) received a structured reminiscence therapy program over five weeks. The intervention was delivered in five small therapy groups, with nine participants in each group. Two 90-minute sessions were conducted per week, for a total of 10 sessions. The sessions addressed age-appropriate reminiscence themes, including getting to know each other, childhood memories, places lived, holidays and festivals, food and cooking, memorable historical periods, favorite music, movies associated with participants' life periods, family life and personal values, life achievements, evaluation, and closure. Photographs, household objects, music, and other reminiscence materials were used to facilitate discussion and recall. |
| Control Group | No intervention | –Participants assigned to the control group (n=45) received no reminiscence therapy or other study intervention during the study period. They completed the baseline and post-test assessments according to the study schedule. |
Who may qualify
- Ages
- 65 to 100 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Older adult
Key inclusion criteria (3 listed)
- Being 65 years of age or older,
- Voluntarily agreeing to participate in the study and providing written consent,
- Suitable for the assessment of psychological well-being and mindfulness levels (e.g., not having disorientation and being able to communicate)
Key exclusion criteria (6 listed)
- Having severe dementia, Alzheimer's, or other neurological diseases,
- Being unable to actively participate in the therapy process due to a severe hearing, vision, or speech impairment,
- Having a diagnosis of psychiatric illness (schizophrenia, bipolar disorder, etc.),
- Having experienced a major traumatic life event in the last six months (death, disaster, serious illness, etc.),
- Having undergone a similar therapeutic intervention or psychotherapy process before,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Reminiscence therapyIn our study, reminiscence therapy was administered for five weeks, with one session per day, twice a week. Each session lasted an average of 1.5 hours, depending on the responses from the elderly participants. The elderly individuals in the experimental group were divided into five groups. Each group consisted of 9 individuals. | Other | Experimental Group |
Primary outcome
Psychological well-being Scale
Time frame: Baseline and immediately after completion of the 5-week intervention
scale score average, It is a single-factor scale consisting of 8 items on a 7-point Likert type. Scores range from 8 to 56. A high score obtained from the scale indicates that the person has many psychological resources and strengths.
1 secondary outcome
Mindful Attention Awareness Scale
Time frame: Baseline and immediately after completion of the 5-week intervention
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Sep 2026.
- Individual participant dataSharing planned: No
Related trials for Healthy Aging
Recruiting
Colon-delivered Riboflavin and Gut Microbiota Composition
Microbiome Dysbiosis, Gut Health
Recruiting
Study Evaluating the Effect of Humiome® Post LB on Stress, Anxiety, and Cognition in Aging Adults
Healthy Aging
Recruiting
Effects of Breathing Exercises on Cognition in Older Adults
Older Adults (65 Years and Older), Cognition
Not yet recruiting
Eccentric Exercise in Community-dwelling Older Adults
Ageing Well
Recruiting
Aquatic Power Training Dosing Strategies and Creatine Supplementation in Older Adults
Aging, Supplementation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Güzel Nur YILDIZ, Dr principal investigator
Muş Alparslan University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Reminiscence therapy in people with Healthy Aging and Aging, run by Muş Alparslan University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Psychological well-being Scale (time frame: Baseline and immediately after completion of the 5-week intervention). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Sep 2026.